Literature DB >> 7857923

Stoichiometry of the atrial natriuretic factor-R1 receptor complex in the bovine zona glomerulosa.

J J Rondeau1, N McNicoll, J Gagnon, N Bouchard, H Ong, A De Léan.   

Abstract

The atrial natriuretic R1 receptor is a membrane protein that is present as an apparently preassociated noncovalent oligomer in the absence of ligand as suggested by steric exclusion studies and cross-linking experiments in physiological and recombinant receptor expression systems. The association state of this receptor oligomer was studied in the presence of amiloride and ATP, two known modulators of the R1 receptor functions with both the intact receptor and a cytoplasmic domain-deleted form obtained by limited proteolysis with trypsin. It was shown by steric exclusion on Superose 6 column that amiloride increased the affinity of ANF for the native and truncated receptor, in contrast with ATP, whose destabilizing effect on ANF binding was abolished by truncation of the cytoplasmic domain. Neither amiloride nor ATP exerts its effects by altering the aggregation state of the receptor. Comparison of the measured number of ANF binding sites with immunoassayable receptor protein revealed that the stoichiometry of ANF binding to the R1 receptor was 1:2. This was confirmed by using an ANF analog that bears a photoactivatable group at both of its ends, showing that ANF, as for the growth hormone/receptor complex, interacts with both the receptor subunits and specifically cross-links a dimeric form of the receptor. The potential pharmacological consequences of this 1:2 stoichiometric ratio of the ANF-receptor complex are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7857923     DOI: 10.1021/bi00007a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

Review 1.  Natriuretic peptide receptor: structure and signaling.

Authors:  Kunio S Misono
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 2.  Photoreceptor guanylate cyclase variants: cGMP production under control.

Authors:  Izabela Sokal; Andrei Alekseev; Krzysztof Palczewski
Journal:  Acta Biochim Pol       Date:  2003       Impact factor: 2.149

Review 3.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

4.  Comparative binding study of rat natriuretic peptide receptor-A.

Authors:  M Marquis; R Fenrick; L Pedro; M Bouvier; A De Léan
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

5.  ATP potentiates competitive inhibition of guanylyl cyclase A and B by the staurosporine analog, Gö6976: reciprocal regulation of ATP and GTP binding.

Authors:  Jerid W Robinson; Lincoln R Potter
Journal:  J Biol Chem       Date:  2011-08-02       Impact factor: 5.157

6.  Structural analysis of natriuretic peptide receptor-C by truncation and site-directed mutagenesis.

Authors:  M Itakura; H Suzuki; S Hirose
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

Review 7.  Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases.

Authors:  Johanne Tremblay; Richard Desjardins; David Hum; Jolanta Gutkowska; Pavel Hamet
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 8.  Intracellular trafficking and metabolic turnover of ligand-bound guanylyl cyclase/atrial natriuretic peptide receptor-A into subcellular compartments.

Authors:  Kailash N Pandey
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

9.  Glycosylation is critical for natriuretic peptide receptor-B function.

Authors:  R Fenrick; N McNicoll; A De Léan
Journal:  Mol Cell Biochem       Date:  1996-12-20       Impact factor: 3.396

10.  Ca(2+) modulation of ANF-RGC: new signaling paradigm interlocked with blood pressure regulation.

Authors:  Teresa Duda; Alexandre Pertzev; Rameshwar K Sharma
Journal:  Biochemistry       Date:  2012-11-07       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.